Predictors of HVTN 503 MRK AD5 HIV-1 Gag/Pol/Nef Vaccine-Induced Immune Response

被引：0
|
作者：
Cerwensky, K. [1 ]
Laher, F. [1 ]
Otwombe, K. [1 ]
Churchyard, G. [2 ]
Bekker, L. [3 ]
Nchabeleng, M. [4 ]
Mlisana, K. [5 ]
Kublin, J. [6 ]
Gray, G. [1 ]
机构：
[1] Univ Witwatersrand, Soweto, South Africa
[2] Aurum Inst Hlth Res, Johannesburg, South Africa
[3] Univ Cape Town, ZA-7925 Cape Town, South Africa
[4] Univ Limpopo, Limpopo, South Africa
[5] Univ KwaZulu Natal, CAPRISA, Kwa Zulu, South Africa
[6] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
来源：
AIDS RESEARCH AND HUMAN RETROVIRUSES | 2013年 / 29卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：A88 / A88
页数：1
相关论文
共 50 条
  • [1] Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef Vaccine Induced Immune Responses
    Hopkins, Kathryn L.
    Laher, Fatima
    Otwombe, Kennedy
    Churchyard, Gavin
    Bekker, Linda-Gail
    DeRosa, Stephen
    Nchabeleng, Maphoshane
    Mlisana, Koleka
    Kublin, James
    Gray, Glenda
    PLOS ONE, 2014, 9 (08):
  • [2] HIV-1 Gag/Pol/Nef immunization in hyper Ad5 immune rhesus macaques using a novel Ad5 platform
    Gabitzsch, E. S.
    Balint, J. P., Jr.
    Xu, Y.
    Balcaitis, S.
    Jones, F. R.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010, 26 (10) : A116 - A117
  • [3] Novel adenovirus type 5 vaccine platform induces cellular immunity against HIV-1 Gag, Pol, Nef despite the presence of Ad5 immunity
    Gabitzsch, E. S.
    Xu, Y.
    Yoshida, L. H.
    Balint, J. P.
    Amalfitano, A.
    Jones, F. R.
    RETROVIROLOGY, 2009, 6
  • [4] Novel Adenovirus type 5 vaccine platform induces cellular immunity against HIV-1 Gag, Pol, Nef despite the presence of Ad5 immunity
    Gabitzsch, Elizabeth S.
    Xu, Younong
    Yoshida, Lois H.
    Balint, Joseph
    Amalfitano, Andrea
    Jones, Frank R.
    VACCINE, 2009, 27 (46) : 6394 - 6398
  • [5] MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load
    Janes, Holly
    Frahm, Nicole
    DeCamp, Allan
    Rolland, Morgane
    Gabriel, Erin
    Wolfson, Julian
    Hertz, Tomer
    Kallas, Esper
    Goepfert, Paul
    Friedrich, David P.
    Corey, Lawrence
    Mullins, James I.
    McElrath, M. Juliana
    Gilbert, Peter
    PLOS ONE, 2012, 7 (08):
  • [6] P19-47. Novel adenovirus type 5 vaccine platform induces cellular immunity against HIV-1 Gag, Pol, Nef despite the presence of Ad5 immunity
    ES Gabitzsch
    Y Xu
    LH Yoshida
    JP Balint
    A Amalfitano
    FR Jones
    Retrovirology, 6
  • [7] HIV-1 vaccine design based on human vaccine trials to improve Gag, Pol, Nef and Env specific immune responses
    Wild, J.
    Kostler, J.
    Bredl, S.
    Bockl, K.
    Kindsmueller, K.
    Wagner, R.
    RETROVIROLOGY, 2009, 6
  • [8] Safety and Immunogenicity of a Multiclade HIV-1 DNA Vaccine Boosted by a Multiclade HIV-1 Ad5 Vaccine in HIV-Uninfected Adult Subjects (HVTN 204)
    Churchyard, G. J.
    Morgan, C.
    Keefer, M.
    Adams, E.
    Hural, J.
    Graham, B.
    Moodie, Z.
    Gray, G.
    Vardas, E.
    Bekker, L.
    McElrath, M. J.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 : 18 - 18
  • [9] Characterizing the Innate Immune Response in HVTN 071, a Trial using MRKAd5 gag/pol/nef from the STEP Study
    Andersen-Nissen, E.
    Duerr, A. C.
    Robertson, M. N.
    Zak, D. E.
    Peterson, E. R.
    Aderem, A.
    De Rosa, S. C.
    McElrath, M. J.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 : 28 - 29
  • [10] Comparative Cell-Mediated Immunogenicity of DNA/DNA, DNA/Adenovirus Type 5 (Ad5), or Ad5/Ad5 HIV-1 Clade B gag Vaccine Prime-Boost Regimens
    Asmuth, David M.
    Brown, Elizabeth L.
    DiNubile, Mark J.
    Sun, Xiao
    del Rio, Carlos
    Harro, Clayton
    Keefer, Michael C.
    Kublin, James G.
    Dubey, Sheri A.
    Kierstead, Lisa S.
    Casimiro, Danilo R.
    Shiver, John W.
    Robertson, Michael N.
    Quirk, Erin K.
    Mehrotra, Devan V.
    JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (01): : 132 - 141
12345